Sort
23,748 grants matching “melanoma”
Translational Applications of mda-7/IL-24 in Cancer
$1,329,682Paul B Fisher · Virginia Commonwealth University · P01 · FY2008 · CA
GENETIC DETERMINANTS OF TUMORIGENESIS
$1,328,824Texas State University-San Marcos · P01 · FY2003 · CA
Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors
$1,327,758Barry A Berkowitz · Bessor Pharma, Llc · R44 · FY2021 · CA
Studies of Receptor Interactions and Effects of Alarmins
$1,327,663Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,327,446Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Comparative Genomics Unit Research
$1,327,152James C Mullikin · National Human Genome Research Institute · ZIA · FY2013 · HG
Cell Migration in 3D microenvironments
$1,325,880Clare Michal Waterman · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Animal Model and Genotyping Core Support Facility
$1,324,639Wendy Du Bois De Vroylande · Division Of Basic Sciences - Nci · ZIC · FY2021 · CA
Preclinical GEM and GDA Models of Primary and Metastatic Melanoma
$1,323,540Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Chemoprevention of Skin Cancer Program Project
$1,323,325David S Alberts · University Of Arizona · P01 · FY2012 · CA
Sphingolipids in Cancer Biology and Therapy
$1,322,890Yusuf Awni Hannun · State University New York Stony Brook · P01 · FY2014 · CA
Role of CEBP transcription factors in regulating cell growth and tumorigenesis
$1,321,912Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
DEFINING THE ROLE OF ABSENT IN MELANOMA 1 (AIM1) IN AGGRESSIVE PROSTATE CANCER
$1,320,000Fred Hutchinson Cancer Research Center · · FY2020 · Defense Health Agency
Genetic Epidermiology of Melanoma
$1,319,383University Of Pennsylvania · R01 · FY2003 · CA
University of New Mexico Cancer Center Support
$1,319,186Cheryl L Willman · University Of New Mexico · P30 · FY2007 · CA
Human Melanoma - Etiology, Progression and Therapy
$1,319,037Meenhard Herlyn · Wistar Institute · P01 · FY2008 · CA
The System of Response to DNA Damage Suppresses Environmental Melanomagenesis
$1,318,947William K Kaufmann · Univ Of North Carolina Chapel Hill · P01 · FY2008 · ES
Preclinical Mouse Models for Studying Immune Checkpoint Inhibitor Response
$1,318,085Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Genetically Engineered Mouse Models to Study Melanoma Genesis and Progression
$1,318,085Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$1,317,817Chi-Chao Chan · National Eye Institute · Z01 · FY2008 · EY
MACROPHAGE-CENTRIC PROGNOSTIC BIOMARKERS FOR CHECKPOINT BLOCKADE IMMUNOTHERAPY IN MELANOMA
$1,317,584University Of Alabama At Birmingham · · FY2025 · Defense Health Agency
Quantitative Biophotonics for Tissue Characterization and Function
$1,312,980Amir H Gandjbakhche · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Chemoprevention of Skin Cancer Program Project
$1,312,638David S Alberts · University Of Arizona · P01 · FY2015 · CA
Studies of Receptor Interactions and Effects of Alarmins
$1,311,888Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer
$1,310,673Cassian Yee · University Of Tx Md Anderson Can Ctr · UG3 · FY2024 · CA